Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone
- PMID: 16763008
- DOI: 10.1093/humrep/del162
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone
Abstract
Background: The objective of this study was to compare cycle control, cycle-related characteristics and bodyweight effects of NuvaRing with those of a combined oral contraceptive (COC) containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Methods: A randomized, multicentre, open-label trial in which 983 women were treated (intent-to-treat population) with NuvaRing or the COC for 13 cycles.
Results: Breakthrough bleeding or spotting during cycles 2-13 was in general less frequent with NuvaRing than that with the COC (4.7-10.4%) and showed a statistically significant odds ratio of 0.61 (95% confidence interval: 0.46, 0.80) with longitudinal analysis. Intended bleeding was significantly better for all cycles with NuvaRing (55.2-68.5%) than that with the COC (35.6-56.6%) (P < 0.01). Changes from baseline in mean bodyweight and body composition parameters were relatively small for both groups with no notable between-group differences.
Conclusion: NuvaRing was associated with better cycle control than the COC, and there was no clinically relevant difference between the two groups in bodyweight.
Similar articles
-
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.Contraception. 2006 Dec;74(6):451-7. doi: 10.1016/j.contraception.2006.07.004. Epub 2006 Sep 27. Contraception. 2006. PMID: 17157101 Clinical Trial.
-
Lower hormone dosage with improved cycle control.Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 2:25-30; discussion 37-9. Eur J Contracept Reprod Health Care. 2002. PMID: 12659399 Review.
-
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).Int J Gynaecol Obstet. 2011 Aug;114(2):145-8. doi: 10.1016/j.ijgo.2011.03.008. Epub 2011 Jun 12. Int J Gynaecol Obstet. 2011. PMID: 21669426 Clinical Trial.
-
Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.Hum Reprod. 2005 Feb;20(2):557-62. doi: 10.1093/humrep/deh604. Epub 2004 Nov 11. Hum Reprod. 2005. PMID: 15539438 Clinical Trial.
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
Cited by
-
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.Contraception. 2022 Feb;106:16-33. doi: 10.1016/j.contraception.2021.10.001. Epub 2021 Oct 10. Contraception. 2022. PMID: 34644609 Free PMC article.
-
Skin patch and vaginal ring versus combined oral contraceptives for contraception.Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD003552. doi: 10.1002/14651858.CD003552.pub4. Cochrane Database Syst Rev. 2013. PMID: 23633314 Free PMC article. Review.
-
A Randomised Controlled Trial Comparing the Efficacy and Side-Effects of Intravaginal Ring (Nuvaring(®)) With Combined Oral Hormonal Preparation in Dysfunctional Uterine Bleeding.J Clin Diagn Res. 2016 Mar;10(3):QC21-4. doi: 10.7860/JCDR/2016/16545.7516. Epub 2016 Mar 1. J Clin Diagn Res. 2016. PMID: 27134949 Free PMC article.
-
Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing).Int J Womens Health. 2010 Nov 12;2:401-9. doi: 10.2147/IJWH.S6162. Int J Womens Health. 2010. PMID: 21151688 Free PMC article.
-
Hormonal contraception--what kind, when, and for whom?Dtsch Arztebl Int. 2011 Jul;108(28-29):495-505; quiz 506. doi: 10.3238/arztebl.2011.0495. Epub 2011 Jul 18. Dtsch Arztebl Int. 2011. PMID: 21814535 Free PMC article.
